September 20, 2018
Rose
The legislation comes in reaction to a law that was geared toward protecting consumer privacy. Drug companies say, though, that it could inadvertently invalidate research, make it difficult to obtain funding and ultimately drive scientists from the state. In other industry news, companies in Massachusetts are being wooed by Maryland, and Europe signs off on another Humira copy.
from Kaiser Health News https://ift.tt/2OImnIF
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment